Investor
Frazier Life Sciences
Palo Alto · United States
Frazier Life Sciences is a biotech investment firm focused on venture and public strategies for novel therapeutics and transformational healthcare innovation.
Stage
Seed–Growth
Sectors
Digital Health
Cheque
Not confirmed
Invests in
Global
Sectors
About
Frazier Life Sciences is a longstanding biotech investment firm with venture and public strategies partnering with and building companies developing novel therapeutics. 9 billion in assets under management to support innovation at every stage of growth. The firm leverages an in-house team and infrastructure to create new companies. Their strategy includes supporting biotech firms as they evolve from initial ideas into fully integrated biotechnology companies through seasoned investing experience.
Portfolio · 4 · tap a company to read about it
Recent deals
- 2026-07Crystalys TherapeuticsSeries BLed
- 2026-06RQ BioSeries A
- 2026-06cAMPfieldSeries A
- 2026-04Sidewinder TherapeuticsSeries BLed
- 2026-03ImmutrinSeries ALed
- 2026-03Vima TherapeuticsSeries A
- 2026-01AirNexis TherapeuticsSeries A
- 2026-01Diagonal TherapeuticsSeries B
- 2026-01AirNexisSeries ALed
- 2025-12Iolyx TherapeuticsSeries B
- 2025-11Braveheart BioSeries A
- 2025-03Hillstar BioSeries A
- 2025-02Callio TherapeuticsSeries A
- 2025-01Alesta TherapeuticsSeries A
- 2024-08Halda TherapeuticsSeries B